Abstract. Though the concept of 'evidence-based medi-is also true that critics not infrequently blame EBM not for what it is, but rather for characteristics that cine' ( EBM ) nowadays has become very popular and even fashionable, its practice is far from being an have never really been attributed to EBM even by its most 'acritical' supporters. Concerns stem mostly from established reality. There are many reasons why, despite its potential, EBM finds obstacles in expressing its the undue emphasis that some 'EBM enthusiasts' have put on the primacy of rigorous methodologies over the full potential as a tool to better inform health care decisions. Broadly speaking, these obstacles fall into complexities of clinical and health care problems and the immediate applicability of scientific evidence to three categories: (i) inadequacy of available information with respect the complexities of health care del-patient care and health care policy decisions.
medicine but especially from patient-centred clinical EBM, it may be worth reviewing briefly why systematic research into the accuracy and precision of diagnostic reviews are an essential component of it. The term tests, the power of diagnostic markers and the efficacy 'systematic' nowadays is used to mark the difference and safety of therapeutics.
from 'traditional (narrative) reviews', a technique that In applying the principles of EBM to his/her every-has been around for a long time as a way to summarize day activities, a good doctor needs to have access to a large body of information on a given topic. clinically important information about diagnosis, proIn contrast to traditional reviews, the term systemgnosis, therapy and other health care issues. In order atic review implies that a review has been prepared to do this, they need to: (i) convert scientific informa-using some kind of explicit and pre-defined approach tion into answerable questions; (ii) identify the best to minimizing biases and random errors, and that the evidence with which to answer them; (iii) critically components of that approach can be documented [7, 8] . appraise that evidence for its validity and usefulness; Other terms, such as 'meta-analysis', have caused conand (iv) apply the results of this appraisal in their fusion because of the implication that a systematic clinical practice.
approach to a review must entail a quantitative sumTo downvalue somewhat the importance of EBM, mary of primary data to yield an overall summary some people say that it is not a new concept and that statistic ('meta-analysis') [9, 10] . Systematic reviews of instead the vast majority of health professionals have research evidence is a fundamental scientific activity always been practising it. Observations of huge vari-[9,11] and its rationale is based on several premises. ations in utilization rates of common surgical and First, large quantities of information must be medical procedures repeatedly reported in the literature reduced into palatable pieces for digestion. Over 2 [2-4] are there to indicate that this is not the case. million articles are published annually in the biomedSimilarly, evidence exists of huge differences in the ical literature in >20 000 journals. Through critical extent to which patients' values are integrated into exploration, evaluation and synthesis, the systematic clinical practice [5, 6 ] , even for interventions that review separates the insignificant, unsound or redundare simple to implement and have good supporting ant deadwood from the salient and critical studies that information behind them. The reasons for these vari-are worthy of reflection. ations cannot be easily understood but they indeed Secondly, various decision makers need to integrate indicate that factors other than scientific evidence have the critical pieces of available medical information. a strong influence on clinical practice. Systematic reviews are of great help to those, such as Having said that, is it possible to identify whether economists or decision analysts, who need to assess and why EBM really brings 'innovations' to health and compare the impact of different types of intervencare theory and practice? The answer is yes, and a tions. Systematic reviews are also of great help to brief account of this is given below.
clinicians to keep abreast of the primary research in a First, EBM enhances our methodological standards.
given field as well as to remain literate in broader The 'EBM' era is characterized by greater emphasis aspects of medicine. Researchers use systematic reviews on controlled and systematic observations as a basis to identify, justify and refine hypotheses, recognize and for scientific inference as opposed to a doctor's peravoid pitfalls of previous work, estimate sample sizes sonal experience. Methods and tools for study design and delineate important ancillary or adverse effects and conduct have also changed.
The availability of more sophisticated statistical and co-variates that warrant consideration in future techniques, together with awareness that reliable evid-studies. Policy makers also use systematic reviews to ence can only be reached through a series of similar formulate guidelines and legislation concerning the use studies on a given issue, represents a second important of certain diagnostic tests and treatment strategies [12] . feature of the 'EBM era'.
Thirdly, the systematic review is an efficient scientific Last but not least, the social context in which technique. Although sometimes arduous and time conscientific information is produced and health care is suming, a review is usually quicker and less costly than delivered have changed dramatically: patients no embarking on a new study. In particular, continuously longer accept being excluded from participating in the up-dated reviews, as produced by the Cochrane decision-making process and increasingly want to have Collaboration, can shorten the time between medical a say in their own care. In this sense, EBM marks research discoveries and clinical implementation of a shift from the 'authoritarian power' of individual effective diagnostic and treatment strategies [13] . experts to the importance attached to the explicit Fourthly, the generalizabilty [14,15] of scientific assessment of the 'strength of evidence'. It thus comes findings can be established in systematic reviews. The as no surprise that most available scales used in its diversity of multiple reviewed studies provides an interassessment put 'expert opinion' as the lowest and the pretative context not available in any one of the results of systematic reviews of several studies as the studies. This is because studies addressing similar queshighest score.
tions often use different eligibility criteria for participants, different definitions of disease, different methods
Systematic reviews as a basis for EBM
of measuring of defining exposure, different variation of a treatment and different study designs. Closely related to generalizability, a fifth reason for If we agree that the three above-mentioned features summarize most of the innovations brought about by systematic reviews is to assess the consistency of rela-A. Liberati et al. 48 tionships. Assessments can be made of whether effects equate in many ways; it gives too much weight to large studies, pays no attention to study quality and makes are in the same directions, and of the same general magnitudes, given the variation in study protocol. no distinction between large and small treatment effects [11] . More specifically, systematic reviews can assess consistency among studies of the same interventions or even among studies of different interventions [16 ] .
Conversely, a sixth reason for systematic reviews is What are the tools for practicing EBM?
to explore data inconsistencies and conflict in data. Whether a treatment strategy is effective in one setting Several tools today can assist doctors willing to practice and not in another or among some patients and not EBM. As already discussed, systematic reviews are in others can be addressed [17] .
being produced at an increasing rate in the medical Seventhly, an often cited advantage of quantitative literature. According to a recent estimate, the number systematic reviews in particular is increased power. of systematic reviews published in medical journals has Lastly, quantitative systematic reviews allow increased grown from 25 in 1987 to >800 in 1996 [21] . precision in estimates of effects [18] .
A second important source of EBM information comes from the so-called 'secondary publications'. Chronologically, the first such journal to appear was
What is special about systematic reviews?
ACP Journal Club, a supplement to Annals of Internal Medicine [22] . Starting in late 1995, another similar An important reason to stress the concept of 'system-journal called Evidence-based Medicine [23] appeared. atic reviews' is the consideration of how different they Both journals survey a large number of general medical are from traditional 'non-systematic' reviews, still an and surgical journals and select articles deemed to be important type of article reported in the medical literat-most relevant for clinical practice. Structured abstracts ure [7] . Traditional reviews use a narrative format to of selected articles are published together with a short summarize the proceedings and findings of studies on commentary prepared by an expert in the field disa coherent topic to attempt to draw conclusions or cussing issues of internal validity and generalizability inform theories [7, 11] . At their best, narrative reviews of findings. Increasing numbers of this type of journal provide insights into the dynamics underlying the are now already available or ready to start publication: findings of individual studies [11] .
Evidence-based Health Policy, Evidence-based Nursing, As much as thoughtful narrative reviews have con-Evidence-based Cardiovascular Disease and Evidencetributed to progress in many areas, even the best of based Mental Health. them have suffered from several key limitations [7] .
A third source of EBM information is represented First, traditional reviews have rarely attempted to be by 'practice guidelines'. It is important to remember exhaustive in their inclusion of studies that meet cer-here that they are broadly defined as '… systematically tain parameters. All too often, narrative reviews have developed statements to assist practitioners and patient emphasized easily available studies, such as those pub-decisions about appropriate health care for specific lished in major journals or those written by the reviewer clinical circumstances …' [24] . Two main types of or their colleagues.
practice guidelines currently exist (though a rigid A constant problem in all research synthesis is distinction can rarely be made): (i) consensus-based 'publication bias': studies that fail to find expected guidelines; and (ii) evidence-based guidelines. The effects of a treatment are less likely to be published main distinction between these two types of guidelines than those that succeed [19] . Reliance on publication lies in the extent to which the processes of panel identiin major journals often overstates the effects of a fication and composition, information identification, treatment [20] . Another serious problem of traditional retrieval and critical appraisal, and an explicit link of reviews is 'reviewer bias' in selecting studies to be the strength of evidence to individual recommendations included. Without a requirement that reviewers clearly is documented explicitly [25] . Though the current specify inclusion criteria, and then exhaustively include balance still largely favours consensus-based guidelines, all studies that fit these criteria, a reviewer may decide, it is likely that EBM guidelines will become increasingly consciously or unconsciously, to include studies that available and that they will eventually facilitate access favour their own biases and ignore those that do not. to evidence-based information for practising clinicians.
A third important problem of traditional reviews is that they rarely apply any systematic method to decide where the weight of the evidence lies. Often, authors
The limitations of EBM of narrative reviews use the 'count method' where they count studies that found significantly positive, nonsignificantly positive, non-significantly negative and The limitations of EBM can be identified on two levels.
The first is more conceptual and depends on the significantly negative results [11] . The reviewer may declare the treatment to be effective if positive out-inherent reductionisms of much clinical research vis a vis the complexity of health care. Average clinical comes substantially outnumber negative ones or if significant positive effects outnumber the sum of non-research looks at the 'ideal' patient, cared for by 'ideal' doctors under 'ideal' circumstances. In contrast, in significant and negative effects. This procedure is inad-'real' life, 'real' patients meet with 'real' doctors in diagnostic hypotheses). It, in fact, depends on the amount of information memorized by individual clini-'real' health care settings.
The second limitation is more practical and depends cians and on their cognitive abilities. EBM is indeed more useful in phase two, when at issue is the refineon the 'relative poverty' limitation of currently available research tools (i.e. methods) that have been ment of a diagnosis from within a selected set of hypotheses or when laboratory or instrumental tests developed and refined satisfactorily more for the investigation of the effects of intervention than for have to be selected. EBM is definitely more useful, though there are often 'grey zones' of uncertainty [29] , settling diagnostic or prognostic questions. It is fair to say, in fact, that despite the emphasis on EBM as a when choices have to be made among different therapeutic approaches, including whether or not to treat a new general approach to the practice of medicine, its main contribution is especially important for therapy. patient and, if yes, how. Its more firm conclusions stem, in fact, from searching, critically appraising and using information about treat-
Hindrances to EBM
ments proved to work through randomized control trials. There is much less evidence-based information on problems related to prognosis and diagnosis, the Besides the limitations outlined above, there are also hindrances that prevent-even when good evidence is latter being essentially limited to the area of precision and accuracy. If we consider the two journals previ-available-the easy translation of EBM information into health care policies. The first has to do with the ously mentioned (i.e. ACP Journal Club and Evidencebased Medicine), 101 of 146 articles selected and difficulty of tailoring indications derived from scientific evidence to the local circumstances of a specific health summarized in the six issues of the latter published between September 1995 and February 1996 referred care setting. The 'old' idea of a hierarchy between scientific evidence and clinical practice is no longer to randomized control trials or meta-analysis of new therapies, and only 11 related to diagnosis. Similarly, tenable as it implies that the former is 'neutral' and value-free: as it stems from a set of methodological in the six issues of ACP Journal Club published in 1996, 83 of 123 articles were trials or meta-analyses on criteria which are generally accepted, its findings are supposed to be generally acceptable and applicable. therapy and 12 on diagnosis. It should not thus come as a surprise that two recent articles that tried to assess Another important hindrance stems from the limited ability of health professionals, and even more so how much of current in-patient [26 ] and out-patient [27] practice is 'evidence-based' concentrated exclus-administrators, to critically appraise and interpret research results. Changes in the social contexts, on the ively on the analysis of the appropriateness of prescribing. In both cases, the thoroughness of diagnosis was other hand, have made the traditional paternalistic relationship between patients and doctors no longer taken a priori, without any attempt at scrutinizing it or assessing its correspondence to EBM standards.
tenable and call for a better way of communicating between a patient and their doctors and the medical Another way to understand where and how EBM is useful to practising clinicians is to look inside the usual community and consumers. This communication is, however, very difficult, and little effort generally is clinical process. At least three distinct phases can be recognized [28] . The first has to do with recognizing made by health care systems to 'promote' themselves.
Implementation of effective health care policies the clinical problem. If the doctors is an expert, and the disease is familiar to him/her, the diagnosis is easily indeed requires proper incentives. A major limitation of efforts aimed at promoting the implementation of made by matching the characteristics of a previously seen patient to the knowledge of the disease. If the effective health care is indeed the inability to identify proper incentives. Despite small differences across doctor is less experienced, or the case is more complex, the reasoning proceeds through a deductive process: different countries, health care systems have concentrated mostly on improving efficiency and controlling several hypotheses are generated and then the more plausible one selected according to the presence/ costs, and there are not many ideas around on how the delivery of effective health care can be promoted. absence of certain symptoms/signs.
The second phase is 'diagnosis verification and comFinally, another hindrance to the implementation of evidence-based practices is the lack of credible and pletion'. Especially if therapeutic decisions are complex, the diagnostic process must be completed taking valid evaluation tools able to assess whether better processes of care do in fact lead to better outcome, into account disease severity, presence/absence of complications, etc. An integral part of this phase is a especially at the population level. thorough assessment of a patient's personal and social characteristics likely to influence his/her prognosis. The Systematic reviews in nephrology: where are we? third phase deals with therapeutic decisions. What matters most here is knowledge of different treatment options, their effectiveness and the 'natural history' of A major force nowadays in the field of systematic review and EBM is the Cochrane Collaboration (CC ), the disease.
If this framework holds, it is then reasonable to an international network of people (including both health professionals and lay consumers) devoted to the conclude that EBM is of limited use for phase one (the recognition of a disease and the generalization of preparation, maintenance and dissemination of system-atic reviews of the effects of health care interventions. displays a list of published reviews by year of publication. Although far from complete, this table nevertheStarted in 1993 in Oxford ( UK ), the CC has evolved rapidly into an international organization with 15 less helps to identify controversial issues, such as, for example, the use of immunosuppressive agents in memCochrane Centres in operation around the world and >30 Collaborative Review Groups busy producing branous nephropathy, which has always puzzled and challenged the nephrologists. systematic reviews collected in the Cochrane Library, the quarterly electronic publication of the CC.
Interestingly, in little more than a few months, 15 potential systematic reviews already at a fairly In 1997, the Renal Review Group was established [29] within the CC. Its main aims are performing and advanced stage of completion have been registered with the Cochrane Collaborative Review Group, showup-dating systematic reviews in the renal field. This new initiative clearly reflects the growing interest in ing the enthusiasm of nephrologists in contributing to the CC. Not surprisingly, more than a half of the clinical medicine, and health care more generally, towards accepting that better decisions can be made registered titles refer to the management of patients with end-stage renal disease. Other interesting topics (both at the bedside and at the population level ) if the totality of evidence in a given area is examined as a are also covered, such as the use of antihypertensives in preventing or delaying the progression of kidney basis to conclude that a given intervention is effective, harmful or has no effect on people's health. This is disease, as shown in Table 2 .
There are several advantages to producing reviews especially important in areas such as nephrology where studies are often under-sized due to the small numbers under the supervision of the CC, but the single most important reason to bear in mind is probably the of patients enrolled. Indeed, since 1984, when only one systematic review on the role of immunosuppression assurance that proper methodology is available and that methodological assistance can be sought if needed. in the management of lupus nephritis was available, >30 articles on different renal topics reported results All Cochrane reviews, in fact, are based on 'hard' endpoints [such as renal death (i.e. death, dialysis or renal of systematic reviews and meta-analyses [30] . 
